{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:12:07Z","timestamp":1788743527497,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2&3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Cessation of cannabinoid use in humans often leads to a withdrawal state that includes sleep disruption. Despite important health implications, little is known about how cannabinoid abstention affects sleep architecture, in part because spontaneous cannabinoid withdrawal is difficult to model in animals. In concurrent work we report that repeated administration of the high-efficacy cannabinoid 1 (CB1) receptor agonist AM2389 to mice for 5 days led to heightened locomotor activity and paw tremor following treatment discontinuation, potentially indicative of spontaneous cannabinoid withdrawal. Here, we performed parallel studies to examine effects on sleep. Using implantable electroencephalography (EEG) and electromyography (EMG) telemetry we examined sleep and neurophysiological measures before, during, and after 5 days of twice-daily AM2389 injections. We report that AM2389 produces decreases in locomotor activity that wane with repeated treatment, whereas discontinuation produces rebound increases in activity that persist for several days. Likewise, AM2389 initially produces profound increases in slow-wave sleep (SWS) and decreases in rapid eye movement (REM) sleep, as well as consolidation of sleep. By the third AM2389 treatment, this pattern transitions to decreases in SWS and total time sleeping. This pattern persists following AM2389 discontinuation and is accompanied by emergence of sleep fragmentation. Double-labeling immunohistochemistry for hypocretin\/orexin (a sleep-regulating peptide) and c-Fos (a neuronal activity marker) in lateral hypothalamus revealed decreases in c-Fos\/orexin+ cells following acute AM2389 and increases following discontinuation, aligning with the sleep changes. These findings indicate that AM2389 profoundly alters sleep in mice and suggest that sleep disruption following treatment cessation reflects spontaneous cannabinoid withdrawal.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000674","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T09:15:46Z","timestamp":1647335746000},"page":"195-205","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Altered sleep during spontaneous cannabinoid withdrawal in male mice"],"prefix":"10.1097","volume":"33","author":[{"given":"Galen","family":"Missig","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyati","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron H.","family":"Good","sequence":"additional","affiliation":[{"name":"Neurolux Inc, Northfield"},{"name":"Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Iliopoulos-Tsoutsouvas","sequence":"additional","affiliation":[{"name":"Department of Pharmceutical Sciences, Center for Drug Discovery, Northeastern University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Makriyannis","sequence":"additional","affiliation":[{"name":"Department of Pharmceutical Sciences, Center for Drug Discovery, Northeastern University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros P.","family":"Nikas","sequence":"additional","affiliation":[{"name":"Department of Pharmceutical Sciences, Center for Drug Discovery, Northeastern University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Paronis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13722-016-0056-7","article-title":"Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.","volume":"11","author":"Angarita","year":"2016","journal-title":"Addict Sci Clin Pract"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"e202370","DOI":"10.1001\/jamanetworkopen.2020.2370","article-title":"Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis.","volume":"3","author":"Bahji","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/sleep\/31.6.901","article-title":"Sleep disturbance in heavy marijuana users.","volume":"31","author":"Bolla","year":"2008","journal-title":"Sleep"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.sleep.2010.02.013","article-title":"Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.","volume":"11","author":"Bolla","year":"2010","journal-title":"Sleep Med"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00952990.2013.821477","article-title":"Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.","volume":"40","author":"Bonn-Miller","year":"2014","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/SAR.S109576","article-title":"The cannabis withdrawal syndrome: current insights.","volume":"8","author":"Bonnet","year":"2017","journal-title":"Subst Abuse Rehabil"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.1205-09.2009","article-title":"Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions.","volume":"29","author":"Carter","year":"2009","journal-title":"J Neurosci"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00437513","article-title":"(-) Delta 9 THC as an hypnotic. An experimental study of three dose levels.","volume":"33","author":"Cousens","year":"1973","journal-title":"Psychopharmacologia"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000514961","article-title":"Twenty-three years of hypocretins: the \u201cRosetta Stone\u201d of Sleep\/Arousal circuits.","volume":"45","author":"de Lecea","year":"2021","journal-title":"Front Neurol Neurosci"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1523\/JNEUROSCI.21-05-01656.2001","article-title":"Fos expression in orexin neurons varies with behavioral state.","volume":"21","author":"Estabrooke","year":"2001","journal-title":"J Neurosci"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt1975174458","article-title":"Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man.","volume":"17","author":"Feinberg","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08897077.2015.1023484","article-title":"Cannabis withdrawal and sleep: a systematic review of human studies.","volume":"37","author":"Gates","year":"2016","journal-title":"Subst Abus"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00213-011-2491-1","article-title":"AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice.","volume":"220","author":"J\u00e4rbe","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13311-021-01013-w","article-title":"Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.","volume":"18","author":"Kaul","year":"2021","journal-title":"Neurotherapeutics"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids, endocannabinoids and sleep.","volume":"13","author":"Kesner","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jnc.15369","article-title":"Cannabis use, abuse, and withdrawal: cannabinergic mechanisms, clinical, and preclinical findings.","volume":"157","author":"Kesner","year":"2021","journal-title":"J Neurochem"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pha0000285","article-title":"The use of cannabinoids for sleep: a critical review on clinical trials.","volume":"27","author":"Kuhathasan","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1523\/JNEUROSCI.3642-17.2018","article-title":"Maternal and early postnatal immune activation produce dissociable effects on neurotransmission in mPFC-Amygdala circuits.","volume":"38","author":"Li","year":"2018","journal-title":"J Neurosci"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/npp.2017.243","article-title":"Perinatal immune activation produces persistent sleep alterations and epileptiform activity in male mice.","volume":"43","author":"Missig","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41380-018-0346-4","article-title":"Sex-dependent neurobiological features of prenatal immune activation via TLR7.","volume":"25","author":"Missig","year":"2020","journal-title":"Mol Psychiatry"},{"key":"R21-20250614","first-page":"37","article-title":"Evidence for spontaneous cannabinoid withdrawal in mice.","volume":"21","author":"Paronis","year":"2021","journal-title":"Behav Pharmacol BP"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.112.199331","article-title":"Diuretic effects of cannabinoids.","volume":"344","author":"Paronis","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"101339","DOI":"10.1016\/j.smrv.2020.101339","article-title":"Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies.","volume":"53","author":"Suraev","year":"2020","journal-title":"Sleep Med Rev"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.01.003","article-title":"Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal.","volume":"117","author":"Vandrey","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1523\/JNEUROSCI.0885-17.2017","article-title":"Effects of chronic social defeat stress on sleep and circadian rhythms are mitigated by Kappa-Opioid receptor antagonism.","volume":"37","author":"Wells","year":"2017","journal-title":"J Neurosci"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"106642","DOI":"10.1016\/j.addbeh.2020.106642","article-title":"Cannabis use and sleep: expectations, outcomes, and the role of age.","volume":"112","author":"Winiger","year":"2021","journal-title":"Addict Behav"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","article-title":"Adaptive linear step-up procedures that control the false discovery rate.","volume":"93","author":"Yoav Benjamini","year":"2006","journal-title":"Biometrika"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:05:23Z","timestamp":1749938723000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":27,"journal-issue":{"issue":"2&3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000674","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}